Truvian Health announced it has raised $74m in funding for its automated benchtop blood testing analyzer, which aims to provide lab-accurate results for a comprehensive suite of routine blood tests in a single run.
The funding round was led by Wittington Ventures and Great Point Ventures with support from existing investors including DNS Capital, Medical Excellence Capital, Tao Capital, TYH Capital and 7wireVentures